Meridian Bioscience (VIVO) Declares $0.20 Quarterly Dividend; 4.7% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Meridian Bioscience (VIVO) Reports In-Line Q4 EPS
November 10, 2016 7:48 AM ESTMeridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $47 million versus the consensus estimate of $47.7 million.Meridian Bioscience reaffirmed FY2017 guidance.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
... More